Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Sci Adv ; 5(3): eaau0790, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30944850

RESUMO

Iron deficiency and anemia are prominent contributors to the preventable disease burden worldwide. A substantial proportion of people with inadequate dietary iron rely on rice as a staple food, but fortification efforts are limited by low iron bioavailability. Furthermore, using high iron fortification dosages may not always be prudent in tropical regions. To identify alternative fortification formulations with enhanced absorption, we screened different iron compounds for their suitability as rice fortificants, measured in vitro gastric solubility, and assessed dietary iron bioavailability using stable isotopic labels in rural Ghanaian children. Isotopic incorporation in red blood cells indicates that in the two age groups of children investigated (4 to 6 and 7 to 10 years), formulations provided 36 and 51% of the median daily requirement in absorbed iron, respectively. We describe approaches to enhancing iron bioavailability from fortified rice, which can substantially contribute to the prevention of iron deficiency in rice-eating populations.


Assuntos
Alimentos Fortificados , Ferro da Dieta/administração & dosagem , Micronutrientes/administração & dosagem , Oryza , Disponibilidade Biológica , Estatura/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Criança , Feminino , Gana , Humanos , Absorção Intestinal , Ferro da Dieta/metabolismo , Ferro da Dieta/farmacocinética , Masculino , Micronutrientes/metabolismo , Micronutrientes/farmacocinética , População Rural/estatística & dados numéricos , Instituições Acadêmicas/estatística & dados numéricos
2.
Int J Obes (Lond) ; 37(1): 24-30, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22945607

RESUMO

BACKGROUND: Many countries in the nutrition transition have high rates of iron deficiency (ID) and overweight (OW). ID is more common in OW children; this may be due to adiposity-related inflammation reducing iron absorption. OBJECTIVE: We investigated whether weight status predicts response to oral iron supplementation in ID South African children. DESIGN: A placebo-controlled trial of oral iron supplementation (50 mg, 4 × weeks for 8.5 months) was done in ID 6- to 11-year-old children (n=321); 28% were OW or obese. BMI-for-age z-scores (BAZ), hepcidin (in a sub-sample), hemoglobin, serum ferritin (SF), transferrin receptor (TfR), zinc protoporphyrin (ZnPP) and C-reactive protein (CRP) were measured; body iron was calculated from the SF to TfR ratio. RESULTS: At baseline, BAZ correlated with CRP (r=0.201, P<0.001) and CRP correlated with hepcidin (r=0.384, P<0.001). Normal weight children supplemented with iron had significantly lower TfR concentrations at endpoint than the OW children supplemented with iron and the children receiving placebo. Higher BAZ predicted higher TfR (ß=0.232, P<0.001) and lower body iron (ß=-0.090, P=0.016) at endpoint, and increased the odds ratio (OR) for remaining ID at endpoint in both the iron and placebo groups (iron: OR 2.31, 95% CI: 1.13, 4.73; placebo: OR 1.78, 95% CI: 1.09, 2.91). In the children supplemented with iron, baseline hepcidin and BAZ were significant predictors of endpoint TfR, with a trend towards a hepcidin × BAZ interaction (P=0.058). CONCLUSION: South African children with high BAZ have a two-fold higher risk of remaining ID after iron supplementation. This may be due to their higher hepcidin concentrations reducing iron absorption. Thus, the current surge in OW in rapidly developing countries may undercut efforts to control anemia in vulnerable groups. The trial is registered at clinicaltrials.gov as NCT01092377.


Assuntos
Anemia Ferropriva/sangue , Ferro/sangue , Sobrepeso/sangue , Anemia Ferropriva/dietoterapia , Anemia Ferropriva/epidemiologia , Peptídeos Catiônicos Antimicrobianos/metabolismo , Biomarcadores/sangue , Proteína C-Reativa/metabolismo , Criança , Suplementos Nutricionais , Feminino , Hemoglobinas/metabolismo , Hepcidinas , Humanos , Inflamação/sangue , Deficiências de Ferro , Masculino , Sobrepeso/dietoterapia , Sobrepeso/epidemiologia , Estudos Prospectivos , Protoporfirinas/sangue , Receptores da Transferrina/sangue , Fatores de Risco , África do Sul/epidemiologia , Transferrina/metabolismo
3.
Eur J Clin Nutr ; 65(1): 20-5, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20842166

RESUMO

BACKGROUND/OBJECTIVES: Ferrous fumarate is recommended for the fortification of complementary foods based on similar iron absorption to ferrous sulfate in adults. Two recent studies in young children have reported that it is only 30% as well absorbed as ferrous sulfate. The objective of this study was to compare iron absorption from ferrous fumarate and ferrous sulfate in infants, young children and mothers. SUBJECTS/METHODS: Non-anemic Mexican infants (6-24 months), young children (2-5 years) and adult women were randomly assigned to receive either 4 mg Fe (women) or 2.5 mg Fe (infants and young children) as either [(57)Fe]-ferrous fumarate or [(58)Fe]-ferrous sulfate added to a sweetened drink based on degermed maize flour and milk powder. Iron absorption was calculated based on incorporation of isotopes into erythrocytes after 14 days. RESULTS: Within each population group, no significant differences (P > 0.05) in iron absorption were found between ferrous fumarate and ferrous sulfate. Mean iron absorption from ferrous fumarate vs ferrous sulfate was 17.5 vs 20.5% in women (relative bioavailability (RBV) =86), 7.0 vs 7.2% in infants (RBV = 97) and 6.3 vs 5.9% in young children (RBV = 106). CONCLUSIONS: Ferrous fumarate is as well absorbed as ferrous sulfate in non-anemic, iron sufficient infants and young children, and can be recommended as a useful fortification compound for complementary foods designed to prevent iron deficiency. Further studies are needed to clarify its usefulness in foods designed to treat iron deficiency.


Assuntos
Laticínios , Compostos Ferrosos/administração & dosagem , Alimentos Fortificados , Zea mays/metabolismo , Adulto , Anemia Ferropriva/prevenção & controle , Bebidas , Disponibilidade Biológica , Pré-Escolar , Avaliação de Medicamentos , Feminino , Compostos Ferrosos/farmacocinética , Compostos Ferrosos/farmacologia , Farinha , Humanos , Lactente , Absorção Intestinal , Ferro/sangue , Ferro da Dieta/administração & dosagem , Ferro da Dieta/farmacocinética , Modelos Lineares , México , Edulcorantes
4.
Eur J Clin Nutr ; 64(5): 490-4, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20197784

RESUMO

BACKGROUND/OBJECTIVES: Iron deficiency and anemia may impair athletic performance, and iron supplements are commonly consumed by athletes. However, iron overload should be avoided because of the possible long-term adverse health effects. METHODS: We investigated the iron status of 170 male and female recreational runners participating in the Zürich marathon. Iron deficiency was defined either as a plasma ferritin (PF) concentration <15 microg/l (iron depletion) or as the ratio of the concentrations of transferrin receptor (sTfR) to PF (sTfR:log(PF) index) of > or =4.5 (functional iron deficiency). RESULTS: After excluding subjects with elevated C-reactive protein concentrations, iron overload was defined as PF >200 microg/l. Iron depletion was found in only 2 out of 127 men (1.6% of the male study population) and in 12 out of 43 (28.0%) women. Functional iron deficiency was found in 5 (3.9%) and 11 (25.5%) male and female athletes, respectively. Body iron stores, calculated from the sTfR/PF ratio, were significantly higher (P<0.001) among male compared with female marathon runners. Median PF among males was 104 microg/l, and the upper limit of the PF distribution in males was 628 microg/l. Iron overload was found in 19 out of 127 (15.0%) men but only 2 out of 43 in women (4.7%). Gender (male sex), but not age, was a predictor of higher PF (P<0.001). CONCLUSIONS: Iron depletion was present in 28% of female runners but in <2% of males, whereas one in six male runners had signs of iron overload. Although iron supplements are widely used by athletes in an effort to increase performance, our findings indicate excess body iron may be common in male recreational runners and suggest supplements should only be used if tests of iron status indicate deficiency.


Assuntos
Anemia Ferropriva/epidemiologia , Exercício Físico/fisiologia , Ferritinas/sangue , Sobrecarga de Ferro/epidemiologia , Ferro da Dieta/metabolismo , Ferro/sangue , Corrida/fisiologia , Adulto , Anemia Ferropriva/sangue , Atletas , Feminino , Humanos , Deficiências de Ferro , Sobrecarga de Ferro/sangue , Ferro da Dieta/administração & dosagem , Masculino , Estado Nutricional , Prevalência , Receptores da Transferrina/metabolismo , Fatores Sexuais
5.
Int J Obes (Lond) ; 32(7): 1098-104, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18427564

RESUMO

BACKGROUND: Overweight is increasing in transition countries, while iron deficiency remains common. In industrialized countries, greater adiposity increases risk of iron deficiency. Higher hepcidin levels in obesity may reduce dietary iron absorption. Therefore, we investigated the association between body mass index (BMI) and iron absorption, iron status and the response to iron fortification in populations from three transition countries (Thailand, Morocco and India). METHODS: In Thai women (n=92), we examined the relationship between BMI and iron absorption from a reference meal containing approximately 4 mg of isotopically labeled fortification iron. We analyzed data from baseline (n=1688) and intervention (n=727) studies in children in Morocco and India to look for associations between BMI Z-scores and baseline hemoglobin, serum ferritin and transferrin receptor, whole blood zinc protoporphyrin and body iron stores, and changes in these measures after provision of iron. RESULTS: In the Thai women, 20% were iron deficient and 22% were overweight. Independent of iron status, a higher BMI Z-score was associated with decreased iron absorption (P=0.030). In the Indian and Moroccan children, 42% were iron deficient and 6.3% were overweight. A higher BMI Z-score predicted poorer iron status at baseline (P<0.001) and less improvement in iron status during the interventions (P<0.001). CONCLUSIONS: Adiposity in young women predicts lower iron absorption, and pediatric adiposity predicts iron deficiency and a reduced response to iron fortification. These data suggest the current surge in overweight in transition countries may impair efforts to control iron deficiency in these target groups. Interactions of the 'double burden' of malnutrition during the nutrition transition may have adverse consequences.


Assuntos
Adiposidade , Anemia Ferropriva/metabolismo , Países em Desenvolvimento , Ferro/metabolismo , Adolescente , Adulto , Biomarcadores/sangue , Índice de Massa Corporal , Criança , Feminino , Ferritinas/sangue , Alimentos Fortificados , Inquéritos Epidemiológicos , Hemoglobinas/análise , Humanos , Índia , Absorção Intestinal , Distúrbios do Metabolismo do Ferro/sangue , Ferro da Dieta/administração & dosagem , Marcação por Isótopo , Masculino , Pessoa de Meia-Idade , Marrocos , Análise Multivariada , Protoporfirinas/análise , Receptores da Transferrina/sangue , Tailândia
6.
Eur J Clin Nutr ; 61(7): 865-9, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17251926

RESUMO

OBJECTIVE: Anemia is a serious public health problem in Indian school children. Since 2003, simple health intervention programs such as antihelminthic treatment and vitamin A supplementation have been implemented in primary schools in the Bangalore region, Karnataka, India. This study examines the prevalence of anemia in school children who are beneficiaries of this program. DESIGN: Cross-sectional survey. SETTING: Bangalore district, South India. SUBJECTS: A total of 2,030 boys and girls, aged 5-15 years, attending schools in the Bangalore district. INTERVENTIONS: School-based, twice yearly intervention: deworming (albendazole 400 mg, single oral dose) and vitamin A supplementation (200,000 IU, single oral dose). MAIN OUTCOME MEASURES: Anemia prevalence based on measure of blood hemoglobin (Hb). RESULTS: Mean age and blood Hb concentration of all children were 9.5+/-2.6 years and 12.6+/-1.1 g/dl (range 5.6-16.7), respectively. The overall anemia prevalence in this group was 13.6%. Anemia prevalence was lower in boys than girls (12.0%; n=1037 vs 15.3%; n=993 respectively, P<0.05). There was no significant difference in anemia prevalence between children in urban and rural locations (14.6 and 12.3%, respectively). CONCLUSIONS: The current low anemia prevalence in Bangalore could be due to the impact of school-based intervention programs that have been in place since 2003. The beneficial interactions of deworming and vitamin A supplementation could have widespread implications for current preventive public health initiatives. There is now need for the development of clear policy guidelines based on these simple and integrated interventions.


Assuntos
Fenômenos Fisiológicos da Nutrição do Adolescente , Anemia Ferropriva/epidemiologia , Anti-Helmínticos/administração & dosagem , Fenômenos Fisiológicos da Nutrição Infantil , Hemoglobinas/análise , Vitamina A/administração & dosagem , Adolescente , Albendazol/administração & dosagem , Anemia Ferropriva/sangue , Anemia Ferropriva/prevenção & controle , Criança , Pré-Escolar , Estudos Transversais , Suplementos Nutricionais , Feminino , Humanos , Índia , Masculino , Prevalência , Saúde da População Rural , Fatores Sexuais , Resultado do Tratamento , Saúde da População Urbana
7.
Int J Vitam Nutr Res ; 71(5): 268-73, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11725691

RESUMO

Women often do not meet the increased iron and folate needs of pregnancy. Maternal iron-deficiency anemia is associated with poor maternal and infant outcomes, including preterm delivery and low birth weight. Poor folate status increases risk for maternal anemia, spontaneous abortion, and congenital defects. Because of this, supplemental iron and folate are often recommended during pregnancy. There are few data on iron and folate status in pregnant women in Switzerland. We measured iron and folate status in a national sample of Swiss pregnant women, estimated the prevalence of anemia, and determined if supplement use is associated with iron and/or folate status in this group. A 3-stage probability to size cluster sampling method was used to obtain a representative national sample of pregnant women (n = 381) in the second and third trimester. We measured hemoglobin, hematocrit, mean corpuscular volume, and serum folate and ferritin concentrations. Serum transferrin receptor concentration was determined in anemic subjects. The use of iron and folate supplements was evaluated by questionnaire. Mean hemoglobin (+/- SD) in the sample was 123 g/L (+/- 1.0). The prevalence of anemia was 6%. Of the 21 anemic women, 11 were iron-deficient, giving an iron-deficiency anemia prevalence of 3%. Nineteen percent of women had low serum ferritin concentrations (< 12 micrograms/L) and 4% had low serum folate concentration (< 2.5 micrograms/L). Supplements containing iron were taken by 65% of women, and 63% were taking folate-containing supplements. Women in the second and third trimester taking folate-containing supplements had significantly higher serum folate concentrations compared to those not taking a folate supplement (p < 0.001). In the third trimester, women taking iron-containing supplements had significantly higher serum ferritin concentrations compared to those not taking an iron-containing supplement (p < 0.01). Our findings indicate that iron and folate status appears to be adequate in the majority of pregnant women in Switzerland, and that use of iron and folate supplements may have a positive impact on status.


Assuntos
Anemia Ferropriva/sangue , Deficiência de Ácido Fólico/sangue , Ácido Fólico/sangue , Ferro/sangue , Adolescente , Adulto , Anemia Ferropriva/prevenção & controle , Suplementos Nutricionais , Feminino , Deficiência de Ácido Fólico/prevenção & controle , Humanos , Inquéritos Nutricionais , Gravidez , Segundo Trimestre da Gravidez/sangue , Terceiro Trimestre da Gravidez/sangue , Suíça
8.
Eur J Clin Nutr ; 54(3): 209-13, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10713742

RESUMO

OBJECTIVES: To determine the efficacy of oral iodized oil in goitrous children who are both selenium (Se) and iodine deficient; to investigate if Se status modifies the response of iodine deficient, goitrous children to oral supplementation with iodized oil. DESIGN: A longitudinal intervention trial. SETTING: Two rural villages in the western Côte d'Ivoire. SUBJECTS: 51 goitrous non-anemic schoolchildren with both iodine and Se deficiency. INTERVENTION: Each child received an oral dose of 0.4 ml iodized poppyseed oil containing 200 mg of iodine. They were followed for 1 y with measurements of urinary iodine (UI), thyrotropin (TSH), thyroxine (T4), and thyroid volume by ultrasound. RESULTS: At baseline all children were goitrous and Se deficient; median UI was 29 microg/l and mean serum Se (s.d.) was 14.8 (10.7) microg/l. After receiving iodized oil, thyroid volume decreased significantly vs baseline at 10, 15, 30 and 50 weeks (P<0.001). At 50 weeks mean percentage change in thyroid volume from baseline was-46.6% and only five children remained goitrous. Median TSH values at 5, 10, 15, 30 and 50 weeks were reduced significantly (P<0.001) compared to baseline. Among individual children the severity of Se deficiency predicted the degree of response to iodized oil. Baseline serum Se and percentage change in thyroid volume from baseline at 50 weeks were strongly correlated (r2=0.554). Baseline Se and percentage decrease in TSH from baseline at 30 weeks were also well-correlated (r2=0.467). CONCLUSION: Although more severe Se deficiency partially blunts the thyroid response to iodine supplementation, oral iodized oil is an effective method for iodine repletion in goitrous children who are Se deficient. SPONSORSHIP: The Swiss Federal Institute of Technology, Zürich, the Foundation for Micronutrients in Medicine, Rapperswil, Switzerland, and the Thrasher Research Fund, Salt Lake City, USA.


Assuntos
Bócio/tratamento farmacológico , Iodo/deficiência , Óleo Iodado/administração & dosagem , Selênio/deficiência , Glândula Tireoide/diagnóstico por imagem , Hormônios Tireóideos/sangue , Índice de Massa Corporal , Criança , Côte d'Ivoire , Feminino , Bócio/sangue , Bócio/diagnóstico por imagem , Humanos , Óleo Iodado/uso terapêutico , Estudos Longitudinais , Masculino , Análise de Regressão , População Rural , Selênio/sangue , Tireotropina/sangue , Tiroxina/sangue , Ultrassonografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA